Title:
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER
Document Type and Number:
WIPO Patent Application WO/2016/160602
Kind Code:
A9
Inventors:
LEE TIEN (US)
KLINGEMANN HANS G (US)
SIMON BARRY J (US)
BOISSEL LAURENT (US)
KLINGEMANN HANS G (US)
SIMON BARRY J (US)
BOISSEL LAURENT (US)
Application Number:
PCT/US2016/024318
Publication Date:
November 24, 2016
Filing Date:
March 25, 2016
Export Citation:
Assignee:
NANTKWEST INC (US)
International Classes:
A61K39/395; A61K35/17; A61K38/16; A61P35/00
Attorney, Agent or Firm:
LOCKYER, Jean M. et al. (Two Embarcadero Center 8th Floo, San Francisco California, US)
Download PDF:
Previous Patent: GENERATING 3D MODELS WITH SURFACE DETAILS
Next Patent: DEVICE COVER AND METHODS INCLUDING THE SAME
Next Patent: DEVICE COVER AND METHODS INCLUDING THE SAME